Peptide library › Immune & inflammation
Cyclosporine
Also known as Ciclosporin, Neoral, Sandimmune, Restasis (eye drops)
Ring-shaped peptide from a fungus that suppresses the immune system; used after transplants and for psoriasis, arthritis and dry eye.
What people use it for
- Preventing organ transplant rejection
- Severe psoriasis and eczema
- Rheumatoid arthritis
- Chronic dry eye (eye drops)
What Cyclosporine does in the body
A cyclic 11-amino-acid peptide that blocks calcineurin, an enzyme T cells need to switch on. That dampens the immune attack on transplanted organs or in autoimmune disease.
Strength of evidence
Strong: transformed transplant medicine from the 1980s.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Kidney damage
- High blood pressure
- Higher risk of infections and some cancers
- Extra hair growth and swollen gums
- Many drug and grapefruit interactions
Who should avoid it or take extra care
- Uncontrolled high blood pressure or kidney disease
- Active serious infection
- Grapefruit and many other medicines interact with it
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved in 1983, followed by Neoral (1995) and Restasis eye drops (2002). Tablets and capsules carry boxed warnings, including for kidney damage and infection.
How it's taken
Route: Capsules or liquid by mouth, drip into a vein, or eye drops
How long it lasts (half-life): About 19 hours on average, varying widely
Latest research & news
- Daratumumab in immune-mediated thrombotic thrombocytopenic purpura: emerging evidence for plasma cell-targeted therapy
Research · Review · PubMed · Hematology · 21 Nov 2026 - Hetrombopag in China: expanding indications, comparative positioning, and risk management - a critical narrative review
Research · Review · PubMed · Hematology · 21 Nov 2026 - Inhibitory effects of the bone marrow microenvironment on erythroid progenitors in pure red cell aplasia
Research · Study · PubMed · Hematology · 21 Nov 2026 - Sirolimus is associated with longer relapse-free survival than cyclosporine in autoimmune hemolytic anemia and evans syndrome: a retrospective cohort study
Research · Study · PubMed · Autoimmunity · 21 Nov 2026 - A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood
Clinical trial · Completed · Phase 1 · Updated · ClinicalTrials.gov · 19 Nov 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Cyclosporine privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Cyclosporine in Fiala How to installMore in Immune & inflammation
- Thymosin Alpha-1Thymus-derived immune-modulating peptide approved in several countries.
- LL-37The only human cathelicidin: an antimicrobial peptide made by the immune system.
- KPVAnti-inflammatory tripeptide taken from the end of alpha-MSH.
- VIPNeuropeptide that relaxes blood vessels and calms immune responses.
- ARA-290Peptide derived from erythropoietin (EPO), studied for nerve pain and inflammation without raising red blood cells.
- ThymulinNatural thymus hormone sold online for immune support and hair growth; no modern human trials.
- NangibotideExperimental drip for septic shock that aims to calm an overactive immune response; it missed its main trial goal.
- EcallantideInjection that stops attacks of hereditary angioedema, a rare condition causing sudden severe swelling.
- IcatibantSelf-injected treatment for sudden swelling attacks in hereditary angioedema.
- ZilucoplanDaily self-injected peptide for generalised myasthenia gravis, an autoimmune condition that causes muscle weakness.